Evaluation of CHROMagar CTX, a novel medium for isolating CTX-M-ESBL-positive Enterobacteriaceae while inhibiting AmpC-producing strains
Author(s) -
Luke Randall,
Miranda Kirchner,
C. J. Teale,
N. G. Coldham,
E. Liébana,
F.A. Clifton-Hadley
Publication year - 2008
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkn485
Subject(s) - microbiology and biotechnology , klebsiella oxytoca , enterobacteriaceae , biology , cefotaxime , enterobacter , klebsiella , escherichia coli , agar , ceftazidime , feces , clavulanic acid , bacteria , pseudomonas aeruginosa , antibiotics , gene , genetics , amoxicillin
The aim of this study was to evaluate CHROMagar CTX (CHROMagar France), a novel agar for the selective isolation of Enterobacteriaceae expressing the bla(CTX-M) gene in the presence of enteric bacteria expressing AmpC enzymes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom